Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Dihydroartemisinin-piperaquine as Seasonal Malaria Chemoprophylaxis in Extended High Transmission Settings of Tanzania: an Open Cluster Randomized Clinical Trial.

NCT05874869 is registered in ClinicalTrials.gov with Richard Mwaiswelo as lead sponsor.

NCT NCT05874869
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05874869 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Dihydroartemisinin-piperaquine as Seasonal Malaria Chemoprophylaxis in Extended High Transmission Settings of Tanzania: an Open Cluster Randomized Clinical Trial.
Lead sponsor
Richard Mwaiswelo
Phase
Not applicable
Overall status
Completed
Start date
July 1, 2020
Completion date
June 30, 2021
Enrollment
13,800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chemoprophylaxis, malaria, underfive children